111 Capital’s Alignment Healthcare ALHC Stock Holding History

111 Capital’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,223	Closed	-$325K	–	452
2025 Q2	$325K	Buy	+23,223	New	+$374K	0.06%	338

Other funds holding ALHC

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

111 Capital's ALHC Position: Q3 2025 in Review

111 Capital sold out of Alignment Healthcare (ALHC) in Q3 2025, closing a stake of 23,223 shares — an estimated $325K sold.

111 Capital first reported a position in ALHC in Q2 2025 and held it in 1 quarter. The position peaked at $325K in Q2 2025. 236 funds tracked by Wall St. Rank hold ALHC as of Q3 2025.

111 Capital reported no remaining Alignment Healthcare position as of Q3 2025 after selling out during the quarter.
111 Capital sold 23,223 Alignment Healthcare shares in Q3 2025, an estimated $325K.
111 Capital first reported a position in Alignment Healthcare in Q2 2025 and held it in 1 quarter.
111 Capital's Alignment Healthcare position peaked at $325K in Q2 2025.
236 funds tracked by Wall St. Rank held Alignment Healthcare as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.